Testing effectiveness (Phase 2)Study completedNCT03535168What this trial is testingRepeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough PatientsWho this might be right forCough Bayer 59
Testing effectiveness (Phase 2)Study completedNCT00239174What this trial is testingStudy to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese PatientsWho this might be right forObesity Sanofi 394
Early research (Phase 1)Study completedNCT02172274What this trial is testingBI 10773 Administered as Oral Solution to Healthy Male VolunteersWho this might be right forHealthy Boehringer Ingelheim 8
Not applicableStudy completedNCT02284074What this trial is testingNasal LPS Challenge in Healthy VolunteersWho this might be right forHealthy Imperial College London 15
Testing effectiveness (Phase 2)Study completedNCT01722318What this trial is testingThe Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)Who this might be right forIrritable Bowel Syndrome Characterized by Constipation Bausch Health Americas, Inc. 428
Large-scale testing (Phase 3)Study completedNCT01039818What this trial is testingComparison of Different Doses of 131I in Severe Graves' HyperthyroidismWho this might be right forGraves Disease Hospital de Clinicas de Porto Alegre 30
Large-scale testing (Phase 3)Study completedNCT01556997What this trial is testingPerindopril Amlodipine for the Treatment of HypertensionWho this might be right forEssential Hypertension Symplmed Pharmaceuticals LLC 837
Early research (Phase 1)Study completedNCT02372097What this trial is testingA Phase 1, Bioequivalence Study of SYR-472 25mg and 50mg TabletsWho this might be right forHealthy Takeda 24
Early research (Phase 1)Study completedNCT05497297What this trial is testingEvaluate the Pharmacokinetics of HSK7653 in Subjects With Renal ImpairmentWho this might be right forRenal Impairment Haisco Pharmaceutical Group Co., Ltd. 42
Not applicableUnknownNCT03173820What this trial is testingClinical Trial in Assigning of Tacrolimus Dosage Regimen According to CYP3A5 Genotype in Kidney Transplant RecipientsWho this might be right forKidney Transplantation Khon Kaen University 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT07193420What this trial is testingReduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological MalignanciesWho this might be right forGVHD - Graft-Versus-Host DiseaseHSCTHaploidentical Stem Cell Transplantation Assistance Publique - Hôpitaux de Paris 180
Large-scale testing (Phase 3)Ended earlyNCT00638482What this trial is testingDose-Dependent Effect of Thiazide in Dent's Disease HypercalciuriaWho this might be right forDent's DiseaseNephrolithiasis Assistance Publique - Hôpitaux de Paris 10
Early research (Phase 1)WithdrawnNCT05252520What this trial is testingJNJ-77474462 (Bermekimab) in Healthy Chinese ParticipantsWho this might be right forHealthy Janssen Research & Development, LLC
Early research (Phase 1)Study completedNCT05925920What this trial is testingStudy of Subcutaneously Administered ENT-03 for the Treatment of Obesity and DiabetesWho this might be right forObesityDiabetes Mellitus, Type 2 Metabolics Pharma 49
Not applicableEnded earlyNCT01924182What this trial is testingIntrathecal Morphine Compared to Conventional Medical Management for Pain Control and Opioid-related Side EffectsWho this might be right forChronic Pain MedtronicNeuro 7
Early research (Phase 1)Ended earlyNCT02289482What this trial is testingA Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy SubjectsWho this might be right forInfection, Human Immunodeficiency Virus GlaxoSmithKline 20
Testing effectiveness (Phase 2)Study completedNCT05868382What this trial is testingStudy to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy AdultsWho this might be right forInfluenza ModernaTX, Inc. 270
Testing effectiveness (Phase 2)Study completedNCT03227224What this trial is testingEvaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant TherapyWho this might be right forDepressive Disorder, Major Janssen Research & Development, LLC 287
Early research (Phase 1)WithdrawnNCT06533280What this trial is testingVH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI)Who this might be right forHIV Infections ViiV Healthcare
Testing effectiveness (Phase 2)Ended earlyNCT01023880What this trial is testingStudy to Determine the Maximum Tolerated Dose and Evaluate the Efficacy and Safety of CEP-18770 (Delanzomib) in Patients With Relapsed Multiple Myeloma Refractory to the Most Recent TherapyWho this might be right forMultiple Myeloma Cephalon 62